Monoclonal Antibodies in Light of Mpox Outbreak: Current Research, Therapeutic Targets, and Animal Models
The rapid rise in monkeypox virus infections among humans from 2022 to 2024 has captured the attention of the global healthcare community. In light of the lack of mandatory vaccination and limited data on next-generation vaccines for monkeypox prevention, the urgent development of therapeutic agents...
Saved in:
| Main Authors: | Vladimir N. Nikitin, Iuliia A. Merkuleva, Dmitriy N. Shcherbakov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Antibodies |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4468/14/1/20 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monkeypox: Current trends and therapeutic challenges
by: Pritama Paul, et al.
Published: (2022-09-01) -
Short-Lived Neutralizing Antibody Responses to Monkeypox Virus in Smallpox Vaccine–Naive Persons after JYNNEOS Vaccination
by: Kara Phipps, et al.
Published: (2025-02-01) -
Monkeypox outbreaks: a comprehensive review of epidemiology, clinical management, and public health responses
by: G. Fatima, et al.
Published: (2025-07-01) -
The Effects of the Combined Co-Expression of GroEL/ES and Trigger Factor Chaperones on Orthopoxvirus Phospholipase F13 Production in <i>E. coli</i>
by: Iuliia A. Merkuleva, et al.
Published: (2024-12-01) -
Comprehensive Insights into Monkeypox (mpox): Recent Advances in Epidemiology, Diagnostic Approaches and Therapeutic Strategies
by: Suresh Kumar, et al.
Published: (2024-12-01)